Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00260741 · ClinicalTrials.gov registry record · Phase 1
Cannabis for Spasticity in Multiple Sclerosis
A Phase 1 study, sponsored by Center for Medicinal Cannabis Research.
- Terminated
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT00260741: Clinical Trial Phase 1 study, sponsored by Center for Medicinal Cannabis Research.
NCT00260741 is a Phase 1 study that was terminated before completion, run by Center for Medicinal Cannabis Research. The registered enrollment target is 60 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00260741, a Phase 1 study, was terminated before completion, sponsored by Center for Medicinal Cannabis Research.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to learn if the use of inhaled cannabis (marijuana) and oral cannabinoid (dronabinol, Marinol or THC, which is an active ingredient of marijuana) is safe and effective in reducing the symptoms of spasticity and tremor in patients with secondary-progressive or primary progressive multiple sclerosis.
Interventions
- DRUG Smoked Cannabis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2003-03 |
| Est. Completion | 2006-01 |
| Phase | Phase 1 |
Why NCT00260741 stopped before completion
NCT00260741 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which Smoked Cannabis is the first listed.
NCT00260741 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00260741 about?
NCT00260741 is a clinical study titled "Cannabis for Spasticity in Multiple Sclerosis". The purpose of this study is to learn if the use of inhaled cannabis (marijuana) and oral cannabinoid (dronabinol, Marinol or THC, which is an active ingredient of marijuana) is safe and effective in reducing the symptoms of spasticity and tremor in patients with secondary-progressive or primary pro...
What is the current status of trial NCT00260741?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2003-03. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00260741?
The interventions under investigation include: Smoked Cannabis (DRUG).
Who is sponsoring clinical trial NCT00260741?
This trial is sponsored by Center for Medicinal Cannabis Research, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00260741's enrollment target sits among peer trials
60 831st of 2000 higher than 1,106 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia